- Home
- Oncology Roadmap Brand Spending Benchmarks and Market Forecast to 2013
Oncology Roadmap Brand Spending Benchmarks and Market Forecast to 2013
This market research was withdrawn from our website upon request of the publisher.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Non-Insulin Diabetes Management: Products, Players, Markets and Forecasts
- $ 3 850
- Industry report
- by Greystone Research Associates
- May 2012
The diabetes market is changing. The convergence of environmental factors, lifestyle factors and increased patient longevity are driving double-digit growth projections for the incidence of non-insulin dependent (Type 2) diabetes globally. Type 2 diabetes accounts for about 90% of all diagnosed cases ...
Industries: Drug and Medication | Countries: Japan, Europe
Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study
- $ 4 650
- Industry report
- by MarketsandMarkets
- May 2012
- 164 pages
Anesthesia is a condition in which sensation is totally or partially blocked. This enables the patients to undergo medical procedures and surgery. Based on the applications (type of surgery or medical procedure) anesthetic drugs are broadly categorized into two types; i.e. local anesthetic drugs and ...
Industries: Drug and Medication | Countries: United States
Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management
- $ 3 500
- Industry report
- by GBI Research
- May 2012
- 91 pages
Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management Summary GBI Research, the leading business intelligence provider, has released its latest research, ?Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to ...
Industries: Drug and Medication
Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs
- $ 3 500
- Industry report
- by GBI Research
- May 2012
- 66 pages
Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs Summary GBI Research, the leading business intelligence provider, has released its latest research ?Drug Price Cuts in Top Five Countries ...
Industries: Drug and Medication | Countries: Europe
Analgesics Market Overview in Brazil
- $ 958
- Industry report
- by Euromonitor International
- May 2012
- 50 pages
2009 was marked by swine flu, which contributed to maintaining strong sales in that year. In 2010, analgesics continued to show robust growth driven by rising disposable income, especially amongst lower-income consumers, who had limited access to medicines in Brazil. According to Euromonitor International ...
Industries: Drug and Medication | Countries: Brazil
Analgesics Market Overview in Spain
- $ 958
- Industry report
- by Euromonitor International
- May 2012
- 34 pages
As the unemployment rate approached 18% at the end of the review period, Spaniards? shopping habits demonstrated change, with price the key variable taken into account when making purchasing decisions. This has resulted in the growing importance of reimbursed products to the detriment of the consume ...
Industries: Drug and Medication | Countries: Spain
Analgesics Market Overview in Colombia
- $ 958
- Industry report
- by Euromonitor International
- May 2012
- 32 pages
There were important launches in analgesics as GlaxoSmithKline de Colombia offered new versions of Dolex. It shows how acetaminophen products are still the first choice for consumers when looking for a pain reliever. This is true despite the new launches in other types of analgesics such as ibuprofen ...
Industries: Drug and Medication | Countries: Colombia
Calming and Sleeping Market Overview in Brazil
- $ 958
- Industry report
- by Euromonitor International
- May 2012
- 34 pages
Although demand for calming and sleeping products remains high, the performance of the category continued to be hindered due to the easy access consumers have to Rx calming and sleeping products such as products based on Valeriana officialis L. Physicians have also been prescribing this type of calming ...
Industries: Drug and Medication | Countries: Brazil
Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Brazil
- $ 958
- Industry report
- by Euromonitor International
- May 2012
- 53 pages
After 2009 that was marked by swine flu, cough, cold and allergy remedies maintained the same pace of growth in 2010. The category grew by 11% in current value terms, registering more than R$3.4 billion. Low unemployment rates and rising disposable income, in particular among lower-income families, contributed ...
Industries: Drug and Medication | Countries: Brazil
Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Spain
- $ 958
- Industry report
- by Euromonitor International
- May 2012
- 36 pages
The initial outbreak of H1N1 influenza observed in Mexico in the first quarter of 2009 caused global concerns due to fears of the potential deadly consequences on humans. In Spain, until October the incidence of the new influenza outbreak was 51 cases in every 100,000 citizens, according to health authorities. ...
Industries: Drug and Medication | Countries: Spain
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- 00 1 718 618 48 97
Reportlinker.com © Copyright 2012. All rights reserved
